Trevena
TRVN
#10609
Rank
NZ$0.01 M
Marketcap
NZ$0.02077
Share price
0.00%
Change (1 day)
-99.26%
Change (1 year)

Trevena (TRVN) - Cash on Hand

Cash on Hand as of September 2024 : NZ$23.3 Million

According to Trevena's latest financial reports the company has NZ$23.3 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Trevena - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$52.14 M-13.61%
2022-12-31NZ$60.35 M-38.4%
2021-12-31NZ$97.97 M-35.38%
2020-12-31NZ$0.15 B185.2%
2019-12-31NZ$53.16 M-42%
2018-12-31NZ$91.65 M-1.52%
2017-12-31NZ$93.07 M-41.71%
2016-12-31NZ$0.15 B-36.7%
2015-12-31NZ$0.25 B84.87%
2014-12-31NZ$0.13 B195.33%
2013-12-31NZ$46.19 M464%
2012-12-31NZ$8.19 M-62.53%
2011-12-31NZ$21.85 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
NZ$16.34 B 70,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$1.66 B 7,050.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$65.61 M 181.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$31.52 B 135,199.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$16.23 M-30.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA